Dubai: Health authorities in the UAE have suspended the sale of an antibiotics brand until the product’s active ingredient is given approval.
The Department of Health in Abu Dhabi pulled out the antibacterial Megamox Powder products, which is manufactured by Jazeera Pharmaceutical Industries, after laboratory tests showed the drugs contained the active ingredient of Amoxicillin.
The sale of the antibiotics will continue to be suspended until the various concentrations of the Amoxicillin ingredient are found safe for public consumption.
All pharmacies have been informed to return the products to the supplier.
Amoxicillin is used for bacterial infections like sinusitis, tonsillitis and other conditions, with a list of possible side-effects that include nausea, vomiting, diarrhoea, cholestatic jaundice and anaemia.
The Ministry of Health and Prevention has also removed a second brand of antibiotics that contained the active Amoxicillin ingredient from the shelves.
The product, called Amoclan Powder for oral suspension products, is manufactured by Hikma Pharmaceuticals in Jordan.
Local health authorities carried out laboratory tests and found that the medicine contained levels of Amoxicillin above the permissible range.